Steven W. Andrews

2.2k citations

23 papers · 725 indexed · h-index 17

Co-authors: J.D. Hillman Gary A. Molander Karyn Bouhana David F. Woodward Eliana B Gómez Barbara J. Brandhuber Karen M. Kedzie S. Michael Rothenberg
Topics: Neuropeptides and Animal Physiology (4 papers)Pain Mechanisms and Treatments (3 papers)Oral microbiology and periodontitis research (3 papers)
Cited by: Periodontics Ophthalmology Pharmacology
Journals: Journal of Clinical Oncology Blood Biochemistry
Partner nations: United States Japan United Kingdom

In The Last Decade

Steven W. Andrews

23 papers receiving 683 citations

Peers

Countries citing papers authored by Steven W. Andrews

Since Specialization

Citations

This map shows the geographic impact of Steven W. Andrews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven W. Andrews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven W. Andrews more than expected).

Fields of papers citing papers by Steven W. Andrews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven W. Andrews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven W. Andrews. The network helps show where Steven W. Andrews may publish in the future.

Co-authorship network of co-authors of Steven W. Andrews

This figure shows the co-authorship network connecting the top 25 collaborators of Steven W. Andrews. A scholar is included among the top collaborators of Steven W. Andrews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven W. Andrews. Steven W. Andrews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 1464: Pre-clinical characterization of potent and selective next-generation RET inhibitors 2021 ·Cancer Research ·Gabrielle R. Kolakowski,Erin D. Anderson,Joshua A. Ballard,Barbara J. Brandhuber,Kevin R. Condroski,Eliana B Gómez,(unknown),Manoj Kumar,Nisha Patel,(unknown),Steven W. Andrews	16
2	Loxo-305, a Highly Selective and Non-Covalent Next Generation BTK Inhibitor, Inhibits Diverse BTK C481 Substitution Mutations 2019 ·Blood ·Eliana B Gómez,(unknown),(unknown),S. Michael Rothenberg,Steven W. Andrews,(unknown)	25
3	LOXO-305, A Next Generation Reversible BTK Inhibitor, for Overcoming Acquired Resistance to Irreversible BTK Inhibitors 2018 ·Clinical Lymphoma Myeloma & Leukemia ·Barbara J. Brandhuber,Eliana B Gómez,Steven G. Smith,(unknown),(unknown),S. Michael Rothenberg,Steven W. Andrews	49
4	Selective inhibition of tropomyosin-receptor-kinase A (TrkA) reduces pain and joint damage in two rat models of inflammatory arthritis 2016 ·Arthritis Research & Therapy ·Sadaf Ashraf,Karyn Bouhana,(unknown),Steven W. Andrews,David A. Walsh	43
5	Characterization of degenerative human facet joints and facet joint capsular tissues 2015 ·Osteoarthritis and Cartilage ·Jae‐Sung Kim,(unknown),(unknown),Xin Li,Jennifer L. Hamilton,Howard S. An,Gabriella Cs‐Szabó,Steven W. Andrews,Mario Moric,Guozhi Xiao,(unknown),Di Chen,John M. Cavanaugh,H.-J. Im	52
6	NTRK1 gene fusions as a novel oncogene target in lung cancer. 2013 ·Journal of Clinical Oncology ·Robert C. Doebele,Aria Vaishnavi,Marzia Capelletti,Anh T. Le,Severine Kako,Mohit Butaney,(unknown),Dara L. Aisner,Julia Haas,Steven W. Andrews,Doron Lipson,Philip J. Stephens,Marileila Varella‐Garcia,Pasi A. Jänne,Vincent A. Miller	9
7	Sustained blockade of neurotrophin receptors TrkA, TrkB and TrkC reduces non-malignant skeletal pain but not the maintenance of sensory and sympathetic nerve fibers 2010 ·Bone ·Joseph R. Ghilardi,Katie T. Freeman,Juan Miguel Jiménez‐Andrade,William G. Mantyh,Aaron P. Bloom,Karyn Bouhana,David Trollinger,James D. Winkler,Patrice Lee,Steven W. Andrews	53
8	Synthesis and SAR of 2-phenyl-1-sulfonylaminocyclopropane carboxylates as ADAMTS-5 (Aggrecanase-2) inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Makoto Shiozaki,Hiroto Imai,Katsuya Maeda,Tomoya Miura,Katsutaka Yasue,(unknown),Masahiro Yokota,(unknown),Julia Haas,Andrew M. Fryer,Ellen R. Laird,(unknown),Steven W. Andrews,John A. Josey,(unknown),Yuichi Shinozaki,(unknown),Takashi Inaba	16
9	Inhibition and Binding Kinetics of the Hepatitis C Virus NS3 Protease Inhibitor ITMN-191 Reveals Tight Binding and Slow Dissociative Behavior 2009 ·Biochemistry ·(unknown),Shawn Misialek,Sarah Stevens,David G. Myszka,Barbara J. Brandhuber,Joshua A. Ballard,Steven W. Andrews,Scott D. Seiwert,Karl Kossen	44
10	750 Preclinical characteristics of ITMN-B, an orally active inhibitor of the HCV NS3/4A protease nominated for preclinical development 2006 ·Journal of Hepatology ·Scott D. Seiwert,Steven W. Andrews,Hua Tan,(unknown),B J Marafino,Robert Rieger,(unknown),(unknown),Ying Jiang,Amy L. Kennedy,Jeanine Ballard,(unknown),Bryan A. Bernat,(unknown),Christine Lemieux,(unknown),John A. Josey,Lawrence M. Blatt	17
11	Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024) 2003 ·Journal of Pharmacology and Experimental Therapeutics ·David F. Woodward,Achim H.‐P. Krauss,(unknown),Yuanbo Liang,(unknown),Charles E. Protzman,A M Bogardus,(unknown),Karen M. Kedzie,(unknown),(unknown),A. Kharlamb,L. A. Wheeler,Darius Babusis,Devin Welty,Diane D‐S. Tang‐Liu,Cherukury Madhu,Steven W. Andrews,Robert M. Burk,Michael E. Garst	115
12	Synthetic Modification of Prostaglandin F_2αIndicates Different Structural Determinants for Binding to the Prostaglandin F Receptor Versus the Prostaglandin Transporter 2000 ·Molecular Pharmacology ·Victor L. Schuster,(unknown),Steven W. Andrews,Robert M. Burk,June Chen,Karen M. Kedzie,Daniel W. Gil,David F. Woodward	24
13	Molecular Characterization and Ocular Hypotensive Properties of the Prostanoid EP ₂ Receptor 1995 ·Journal of Ocular Pharmacology and Therapeutics ·David F. Woodward,A M Bogardus,John E. Donello,Craig Fairbairn,Daniel W. Gil,Karen M. Kedzie,(unknown),A. Kharlamb,(unknown),Steven W. Andrews,Kristen L. Pierce,John W. Regan	24
14	An EP receptor with a novel pharmacological profile in the T‐cell line Jurkat 1995 ·British Journal of Pharmacology ·Gerald W. De Vries,Peter Guarino,A.P. McLaughlin,(unknown),Steven W. Andrews,David F. Woodward	21
15	Adaptive Changes in a Strain ofStreptococcus mutansduring Colonisation of the Human Oral Cavity 1989 ·Microbial Ecology in Health and Disease ·J.D. Hillman,Steven W. Andrews,(unknown),Philip Stashenko	16
16	Bis(trimethylsilyl) enol ethers as 1,3-dianion equivalents: Regiocontrolled [3+4] and [3+5] annulation reactions 1989 ·Tetrahedron Letters ·Gary A. Molander,Steven W. Andrews	18
17	Chelation control in the intramolecular addition of allylsilanes to carbonyl electrophiles 1988 ·Tetrahedron ·Gary A. Molander,Steven W. Andrews	8
18	Colonization of the Human Oral Cavity by a Streptococcus mutans Mutant Producing Increased Bacteriocin 1987 ·Journal of Dental Research ·J.D. Hillman,(unknown),Steven W. Andrews	90
19	Acetoin production by wild-type strains and a lactate dehydrogenase-deficient mutant of Streptococcus mutans 1987 ·Infection and Immunity ·J.D. Hillman,Steven W. Andrews,(unknown)	24
20	Chelation-controlled cyclization of β-ketoester-substituted and β-ketoamide-substituted allylsilanes. 1986 ·Tetrahedron Letters ·Gary A. Molander,Steven W. Andrews	13

About Steven W. Andrews

Steven W. Andrews is a scholar working on Periodontics, Pharmacology and Pharmaceutical Science, having authored 23 papers that have together received 725 indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (4 papers), Pain Mechanisms and Treatments (3 papers) and Oral microbiology and periodontitis research (3 papers). The work is most often cited by research in Periodontics (68 citations), Ophthalmology (80 citations) and Pharmacology (127 citations). Steven W. Andrews has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include J.D. Hillman, Gary A. Molander, Karyn Bouhana, David F. Woodward, Eliana B Gómez, Barbara J. Brandhuber, Karen M. Kedzie, S. Michael Rothenberg, Robert M. Burk and Sadaf Ashraf. Their work appears in journals such as Journal of Clinical Oncology, Blood and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact